Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Stroke

In brief

The purpose of this study is to evaluate the effect of six intravenous (IV) infusions of magnesium chloride versus placebo in patients who have residual muscle weakness from a stroke that occurred three months to four years ago.

Key facts

Study ID

NCT00933868

Run by

Relox Medical, LLC

People needed

81

Starts

2009-04-01

Expected to finish

2010-07-01

Last updated by the study team

2012-05-25

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects of either sex above 18 years of age
• Documented history of stroke 3 months to four years ago
• Subjects may have had two or more strokes
• Must have residual muscle weakness with a 25% or greater difference in strength between the right and left sides of the body
• Must be assessed as a 2 or 3 on the Modified Rankin Scale
• Must have a Barthel score at or below 85

You may not qualify if…

• Any traumatic brain injury or other brain injury apart from stroke
• Renal insufficiency or renal failure
• Any medical or physical condition that would interfere with the measurements to be conducted
• Any physical therapy in a facility outside their home within three days of screening

Where it is running

• Born Preventive Healthcare Clinic, PC — Grand Rapids, Michigan, United States
• Schachter Center for Complementary Medicine — Suffern, New York, United States
• Comprehensive Heart Care Inc. — Toledo, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.